Interview with Luciano Marques, Novartis South Africa
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Address: 72-74 Steel Road
Spartan
Kempton Park
Gauteng
1619 South Africa
Tel: +27.11.929.9111
Web: http://www.novartis.co.za/index.asp
Novartis was created in 1996 from the merger of the Swiss companies, Ciba-Geigy and Sandoz. Our name, ‘Novartis’ derived from the latin ‘novae artes’ means ‘new skills’.
In 2006, Novartis celebrated 10 years of helping patients worldwide since the successful creation of a health care leader through the merger. With its headquarters in Basel, Novartis operates in 140 countries and has more than 98 000 employees.
Novartis South Africa embodies Novartis core corporate purpose, which is to ‘Care and Cure’, putting the patient at the centre of all that we do.
Patient centricity is the common theme that runs through our diverse businesses and products represented by, Novartis Pharmaceuticals, Over the Counter Medicines(OTC), Animal Health, Ciba Vision and Sandoz Generics in South Africa.
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of employees for multinational organizations.…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa is in an interesting…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have you integrated these changes…
An emerging country with a dynamic market, South Africa is widely seen as the gateway to Africa. From major multinational pharmaceutical corporations to burgeoning local generic companies, a wide…
We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are interviewing you today at the head…
Dr Pillay, South Africa recently became a member of BRICS. With this distinction, we need to improve our healthcare outcomes relative to other BRICS countries. All countries have challenges with…
The South African affiliate was established in June 2003. Could you come back on the main milestones in the company’s development from 2003 onwards? Yamanouchi as an entity was an…
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market place, and within Sanofi as an organization? The…
In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you have significantly grown in the market since then. What new…
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your personal country portfolio?…
See our Cookie Privacy Policy Here
